Alert: New Earnings Report (3/21/24)-Fennec Pharmaceuticals Inc (NASDAQ: FENC).
Fennec Pharmaceuticals Inc (NASDAQ: FENC) has reported E.P.S. of $-0.10 for its fourth fiscal quarter (ending December 31) versus $-0.26 for the same period a year ago. For the latest four quarters through December 31, […]